Literature DB >> 11247325

The modulation of chlamydial replication by HLA-B27 depends on the cytoplasmic domain of HLA-B27.

J G Kuipers1, A Bialowons, P Dollmann, M C Jendro, L Koehler, M Ikeda, D T Yu, H Zeidler.   

Abstract

OBJECTIVE: The intracellular persistence of viable Chlamydia trachomatis (CT) within the joint is thought to initiate and maintain the inflammatory process in CT-induced arthritis. CT-induced arthritis is associated with HLA-B27. Recently it was shown that HLA-B27, besides being a T-cell restriction element, can directly influence the invasion and/or replication of enterobacteriae and alters salmonella-induced signal transduction. It was the aim of this study to analyze the effect of HLA-B27 on CT-invasion and replication in human host cells.
METHODS: Human Hela cells and Hela cells transfected with either HLA-B27 cDNA or controls (HLA-A1 cDNA; HLA-B27 mutant = HLA-B27 without cytoplasmic tail; B27Q10 = HLA-B27 Exon 1-4 linked to Exon 5 of murine Q10) were infected with CT. By direct immunofluorescence chlamydial invasion was determined 4 hours post infection (p.i.), chlamydial replication 2 days and 4 days p.i. The number of infective CT in the different cell lines was determined by titration of the cell lysates on Hep-2 cells with subsequent immunoperoxidase staining.
RESULTS: Invasion was not affected by HLA-B27. However, formation of chlamydial inclusion bodies and replication was suppressed by HLA-B27. Genetically engineered mutants of HLA-B27 (HLA-B27 mutant, B27Q10) lacking the cytoplasmic tail of HLA-B27 did not affect replication.
CONCLUSION: The reduction of chlamydial replication by HLA-B27 depends on the cytoplasmic domain of HLA-B27, thus providing a new hypothesis for chlamydial persistence in HLA-B27 positive reactive arthritis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11247325

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  3 in total

1.  HLA-B27 expression does not modulate intracellular Chlamydia trachomatis infection of cell lines.

Authors:  J L Young; L Smith; M K Matyszak; J S Gaston
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

Review 2.  Treatment of reactive arthritis with biological agents: a review.

Authors:  Huiqiong Zeng; Baiwei Luo; Yue Zhang; Zhongyu Xie; Zhizhong Ye
Journal:  Biosci Rep       Date:  2020-02-28       Impact factor: 3.840

Review 3.  Reactive Arthritis: Update.

Authors:  Ibtissam Bentaleb; Kawther Ben Abdelghani; Samira Rostom; Bouchra Amine; Ahmed Laatar; Rachid Bahiri
Journal:  Curr Clin Microbiol Rep       Date:  2020-09-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.